We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ureteral Stent Length and Patient Symptoms

This study has been terminated.
(Because no staff to consent or enroll subjects)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00288457
First Posted: February 8, 2006
Last Update Posted: December 24, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
John G Pattaras, MD, Emory University
February 6, 2006
February 8, 2006
December 24, 2013
February 2006
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00288457 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Ureteral Stent Length and Patient Symptoms
Not Provided
The Study of whether or not Ureteral Stent Length affects patient comfort after electro-shock wave treatment for kidney stones.
Patients undergoing electro shock wave for treatment of kidney stones are randomized to long or short stent length after signing an informed consent prior to their surgery. They keep a pain diary and medication diary for a two week period after the stent is placed. These are turned in at the two week post-op visit. Patients also complete a quality of life and urinary symptom score questionnaire pre and post operatively.
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Male or female over 18 years of age, will be receiving electro-shock wave therapy for kidney stones
Kidney Stones
Device: Ureteral Stent
Ureteral stents are not investigatory but rather part of standard of care. In this study, we were interested in having patients fill out pre and post-operative questionnaires so that we could compare their symptoms with the length of their ureter and the stent placed.
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
1
October 2006
Not Provided

Inclusion Criteria: Male or female over 18 years of age, will be receiving electro-shock wave therapy for kidney stones -

Exclusion Criteria:Under 18 years of age, inability to give informed consent

Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
United States
 
NCT00288457
0758-2003
Not Provided
Not Provided
Not Provided
John G Pattaras, MD, Emory University
Emory University
Not Provided
Principal Investigator: John G Pattaras, MD Emory University
Emory University
December 2013